Berlinger Special AG: Doping Sample Security is the Paramount Priority

Food and Healthcare Press Releases Wednesday January 31, 2018 09:52
GANTERSCHWIL, Switzerland--31 Jan--PRNewswire/InfoQuest

The doping samples taken at the coming Olympic Winter Games in PyeongChang, South Korea will be capable of being securely closed and stored. Sample bottle manufacturer Berlinger Special AG is currently assessing any security weaknesses in collaboration and close contact with the World Anti-Doping Agency (WADA) and is also planning additional security measures.

The secure handling and storage of doping samples - at the Olympic Winter Games and in general - is the mission and the goal of sample security bottle manufacturer Berlinger Special AG. In view of this, Berlinger Special AG takes seriously the recent video-documented tests by the team of investigative journalists, even though the testing methods used are not known, and even though their findings contradict the results of the extensive tests conducted both by Berlinger Special AG and by independent specialists on the bottles concerned, which showed in all cases that the bottles worked reliably when correctly handled.

(Photo: https://mma.prnewswire.com/media/635225/Berlinger_Special_AG_Doping_Security.jpg )
(Photo: https://mma.prnewswire.com/media/635224/Berlinger_Special_AG_Doping_Samples.jpg )

What cannot be said of the sample bottles currently used (as is claimed in the film) is that they cannot be distinguished from counterfeits: Berlinger Special AG can always identify its own products beyond any doubt, thanks to a number of secret company-specific features that are integrated into the product.

Improved closing mechanism under consideration

Should security shortcomings be confirmed, Berlinger Special AG will take additional measures to safeguard the samples collected at the coming Olympic Winter Games in PyeongChang. Among the options here, Berlinger Special AG is considering the use of doping sample containers with a modified closing mechanism that cannot be incorrectly handled. Corresponding trials are currently under way, and all the results of these will be made available.

Berlinger Special AG is making every possible effort, in collaboration with WADA and the IOC, to provide secure doping sample solutions that ensure clean competition and credible controls. The results of the current trials, and of any decisions taken in the light thereof, will be communicated without delay.

Further information:
Berlinger Special AG
Media Relations
c/o. KMES Partner I KLAUS
Hans Klaus
Basteiplatz 7
CH-8001 Zurich
Phone: +41-43-544-1744
Email: office@kmespartner.com
Source: Berlinger Special AG

Latest Press Release

Menicon Announces Launch of Menicon Bloom Myopia Control Management System

- Launch Features Initial Introduction of Menicon Bloom Night, First and Only CE-approved Orthokeratology Contact Lens in Europe for Myopia Control - Menicon Co., Ltd. announced on May 24 the launch of the Menicon Bloom Myopia Control Management System,...

Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event

- Global health leaders covered biomanufacturing and neglected tropical diseases (NTDs) during 72nd World Health Assembly - Event focused on innovative science and technology-based solutions to increase access to medicines and biologics Merck, a...

Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different Projects in Oncology

Menarini Ricerche will present three different projects related to the compounds in clinical development SEL24/MEN1703, MEN1611 and MEN1309/OBT076 at the ASCO Annual Meeting 2019 in Chicago. During the poster session "Breast Cancer – Metastatic"...

Surgical Specialties Corporation Launches Caliber Ophthalmics Division to Focus on Global Growth of Ophthalmic Surgical Procedures

Surgical Specialties Corporation (SSC) announced today the launch of Caliber Ophthalmics, a new business division. Caliber Ophthalmics combines SSC's Sharpoint(TM) brand, which has earned a trusted reputation serving ophthalmic surgeons for over 50...

After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor

Ori Yehudai: "I took a company worth $3 million and sold it to IFF at $7.1 billion in 2018. In my opinion, the success of our cannabis company will be to build an industrial pharmaceutical company with the strictest standards, we had two such plants, and...

Related Topics